Coronavirus (Covid-19) Cases: The recovery rate is 65.76 per cent.
New Delhi: Coronavirus Live Updates: India's COVID-19 tally crossed the 18-lakh mark on Monday, with 52,972 cases being reported in a day. The country now has 18,03,695 infections of the deadly virus which has affected more than 18 million people globally. With 771 COVID-19 deaths in the last 24 hours, the number of deaths count has climbed to 38,135, the government said. More than 11.86 patients have recovered; the recovery rate stood at 65.76 per cent this morning. India has tested a total of 2,02,02,858 samples so far. The positivity rate - percentage of patients who have tested positive for coronavirus - stood at 13.90 per cent.
Meanwhile, Union Home Minister Amit Shah and Karnataka Chief Minister BS Yediyurappa have tested positive for coronavirus.
According to the sources said Amit Shah has been admitted to Medanta hospital, located in Haryana's Gurugram near Delhi.
Here are the Live Updates on Coronavirus (COVID-19) Cases:
Millions Return To Lockdown In Philippines As Virus Cases Soar
More than 27 million people in the Philippines -- about a quarter of the population -- will go back into lockdown Tuesday after overwhelmed health workers warned the country was losing the battle against the coronavirus.
Since the beginning of June, when much of the country emerged from one of the world's longest stay-at-home orders, confirmed infections in the archipelago have increased fivefold, surging past 100,000.
The new restrictions announced by President Rodrigo Duterte late Sunday apply to the capital Manila and four surrounding provinces on the main island of Luzon.
JustIn| Coronavirus cases in India cross 18-lakh mark, 38,135 deaths
Top Coronavirus Advisor Warns US In "New Phase" Of Pandemic
The United States has entered a "new phase" of the pandemic, White House coronavirus advisor Deborah Birx warned Sunday, with rural areas just as threatened as major cities.
Birx, who heads the White House coronavirus task force, told CNN's "State of the Union" that local virus mitigation procedures were starting to work, but added that "what we are seeing today is different from March and April".
"It is extraordinarily widespread. It's into the rural as equal urban areas," she added. "To everybody who lives in a rural area, you are not immune or protected from this virus."
BS Yediyurappa Tests Covid +ve, Hospitalised, Daughter Also PositiveKarnataka Chief Minister BS Yediyurappa tweeted late Sunday night that he had tested positive for the novel coronavirus. In a brief post on Twitter, Mr Yediyurappa said that he was fine but had been hospitalised on the advice of doctors. While his daughter Padmavathi has also tested positive for the virus, the Chief Minister's son, Vijayendra, has tested negative.
Read more
Virus Exposes Cracks In Brazil's Public Health System
Brazil's public health care system, considered among the world's most advanced when it was launched, is being pushed to the brink by the coronavirus pandemic, which has exposed the impact of years of under-funding and mismanagement.
As Brazil closes in on 100,000 deaths from COVID-19 -- the second country in the world to reach that bleak milestone, after the United States -- the public health care system is struggling to care for those who depend on it.
Launched in 1988, the so-called SUS -- for Sistema Unico de Saude, or Single Health System -- was modeled on Britain's National Health Service (NHS).
Covid-19: Raigarh Police To Distribute Over 7 Lakh Masks To Raise Awareness
On the occasion of Raksha Bandhan, Raigarh Police will distribute over seven lakh masks on Monday to raise awareness about COVID-19, the state police said.
Santosh Kumar Singh, Superintendent of Police said, "We have planned to distribute around seven to eight lakh masks. We are doing this to raise awareness as a part of our social duty.
According to an official release, a mask is a foremost measure to safeguard against the infection and hence Raigarh police have organised a mega awareness campaign named "Ek Rakshasutra mask ka", on the occasion of Raksha Bandhan.
Jodhpur Restaurant Sells COVID Curry, Mask Naan, Leaves Customers Intrigued
While COVID-19 continues to spread, a restaurant in Jodhpur has infused creativity in its menu by adding COVID-19-themed dishes. The Vedic restaurant is serving new and unique "COVID Curry" and "Mask Naan" to its customers.
The COVID Curry is basically "malai kofta" made in the shape of the COVID-19 while the ''Mask Naan'' is a facemask-shaped naan.
Restaurant's owner, Anil Kumar says these two new dishes are his brainchild.
Assam Government Issues Guidelines On Permissible Activities In StateThe Assam government has issued guidelines regarding permissible activities in the state which will come into effect from 7 PM on Sunday and remain valid till 7 PM of August 14.
Inter-district movement is allowed on Monday and Tuesday only. No separate permission/approval/e-permit will be required.
Malls and gymnasiums are allowed to operate between Monday and Friday on the same side of the street on which other shops are allowed in Kamrup Metropolitan District and both sides in the case of all other districts.
Movement of individuals strictly prohibited between 6 PM and 6 AM.
"After due consideration of the COVID situation as it prevails in the state of Assam and taking into consideration latest directives issued by the Union Ministry of Home Affairs dated 29 July 2020, the following modifications of the order dated 18 July, 2020 are allowed in the entire State of Assam: This order shall come into force with effect from 7 PM of 2 August, 2020 and remain valid till 7 PM of 14 August, 2020," the order from the Assam government read.
1,178 new COVID-19 cases detected out of 19,943 tests conducted in last 24 hours. We have been able to maintain a low positivity rate consistently (today- 5.91%). Total number of cases now at 42,904 including 11,354 active cases & 105 deaths: Himanta Biswa Sarma, Assam Health Minister
Global Coronavirus Cases Cross 18 Million Mark With Over 687,000 DeathsThe number of coronavirus cases recorded worldwide has passed 18 million, according to an AFP tally from official sources at 2240 GMT Sunday.
At least 18,011,763 cases have now been registered as the pandemic's rate of infection continues to accelerate. A million more cases have been detected in just the last four days.
More than half of the world's cases have been recorded in the United States and in Latin America and the Caribbean region.
The United States is the worst-hit country with 4,657,693 cases including 154,793 deaths, followed by Brazil, with 2,733,677 cases and 94,104 deaths.
The third worst-hit country is India, with 1,750,723 cases and 37,364 deaths.
Worldwide, there have been 687,941 deaths.
The tallies, using data collected by AFP from national authorities and information from the World Health Organization (WHO), probably reflect only a fraction of the actual number of infections.
Many countries are testing only symptomatic or the most serious cases.
Serum Institute Gets Nod For Phase 2,3 Human Trial Of Oxford COVID VaccineThe Drugs Controller General of India (DCGI) has given nod to the Serum Institute of India (SII) for conducting phase 2 and 3 human clinical trials of a COVID-19 vaccine candidate, developed by the University of Oxford, in the country.
Government officials told PTI that the approval for conducting phase 2 and 3 clinical trials by the SII was granted by DCGI Dr V G Somani late Sunday night after a thorough evaluation based on the recommendations of the Subject Expert Committee on COVID-19.
As a rapid regulatory response, the expert panel at the Central Drugs Standard Control Organisation (CDSCO) on Friday, after a detailed deliberation and considering the data generated on the vaccine candidate in phase 1 and 2 of the Oxford University trial, had recommended granting permission for phase 2 and 3 clinical trials of the potential vaccine, "Covishield", on healthy adults in India, the officials said.
"The firm has to submit safety data, evaluated by the Data Safety Monitoring Board (DSMB), to the CDSCO before proceeding to phase 3 clinical trials," a senior official said.
"As per the study design, each subject will be administered two doses four weeks apart (first dose on day one and second dose on day 29) following which the safety and immunogenicity will be assessed at predefined intervals," the official said.